Director Dealings

Transactions

Dealing dateCompany / TickerName / TitleSharesPer shareDeal size
Sale02 Apr 2026Halozyme Therapeutics IncHALO:NSQHelen I. TorleyDirector, President and Chief Executive Officer15,80064.06 USD1.01m USD
Sale02 Apr 2026Halozyme Therapeutics IncHALO:NSQHelen I. TorleyDirector, President and Chief Executive Officer4,20064.89 USD272.53k USD
Purchase02 Apr 2026Lipocine IncLPCN:NAQMahesh V. PatelDirector, President, Chief Executive Officer and Principal Financial Officer25,0002.02 USD50.50k USD
Sale02 Apr 2026RingCentral IncRNG:NYQRobert TheisIndependent Director2,42937.85 USD91.94k USD
Sale02 Apr 2026RingCentral IncRNG:NYQRobert TheisIndependent Director10038.80 USD3.88k USD
Sale02 Apr 2026RingCentral IncRNG:NYQAmy Guggenheim ShenkanDirector1,26437.93 USD47.94k USD
Purchase02 Apr 2026Cloudcoco Group PLCCLCO:LSESimon D'Olier DuckworthNon-Executive Director,Chairman104,166,6670.0012 GBP125.00k GBP
Purchase02 Apr 2026Cloudcoco Group PLCCLCO:LSESimon D'Olier DuckworthNon-Executive Director,Chairman70,833,3330.0012 GBP85.00k GBP
Purchase02 Apr 2026Cloudcoco Group PLCCLCO:LSESimon D'Olier DuckworthNon-Executive Director,Chairman2,233,3330.0021 GBP4.78k GBP
Sale02 Apr 2026Cardlytics IncCDLX:NMQAmit GuptaChief Executive Officer and Director54,2251.04 USD56.50k USD
Sale02 Apr 2026Samsara IncIOT:NYQSanjit BiswasChief Executive Officer and Chairman of the Board9,75830.93 USD301.84k USD
Sale02 Apr 2026Samsara IncIOT:NYQSanjit BiswasChief Executive Officer and Chairman of the Board62331.63 USD19.71k USD
Sale02 Apr 2026Samsara IncIOT:NYQJohn BicketExecutive Vice President, Chief Technology Officer and Director9,30930.91 USD287.76k USD
Sale02 Apr 2026Samsara IncIOT:NYQJohn BicketExecutive Vice President, Chief Technology Officer and Director70031.62 USD22.13k USD
Purchase02 Apr 2026Foresight Ventures VCT plcFVEN:LSEStella PanuNon-Executive Director11,3120.884 GBP10.00k GBP
22798 total results
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.
www.morningstar.com